GREGORY P HANSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY P HANSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY P HANSON. GREGORY P HANSON is Vice President, CAO in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Vice President, Finance in AVANIR PHARMACEUTICALS, INC. ($AVNR) and VP, CAO & Secretary in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Chief Financial Officer in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and CHIEF FINANCIAL OFFICER, SECR in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
Latest Insider Trading Transactions of GREGORY P HANSON
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
Jan 18 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.92 | 41,873 | 38,523 | 320,013 | 361.9 K to 320 K (-11.57 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 449,159 | 0 | 0 | |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.96 | 11,232 | 10,783 | 361,886 | 373.1 K to 361.9 K (-3.01 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.98 | 38,697 | 37,923 | 373,118 | 411.8 K to 373.1 K (-9.40 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 0.96 | 66,550 | 63,888 | 411,815 | 478.4 K to 411.8 K (-13.91 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | M | 0.00 | 449,159 | 0 | 478,365 | 29.2 K to 478.4 K (+1,537.90 %) |
Oct 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 340,420 | 0 | 340,420 | |
Sep 18 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 108,739 | 0 | 108,739 | |
Aug 02 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | S | 6.29 | 3,119 | 19,619 | 0 | |
Aug 02 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | S | 5.55 | 3,119 | 17,310 | 0 | |
Aug 02 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | P | 0.00 | 4,842 | 0 | 38,334 | 33.5 K to 38.3 K (+14.46 %) |
Aug 02 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | P | 1.75 | 4,286 | 7,501 | 33,492 | 29.2 K to 33.5 K (+14.68 %) |
Apr 14 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.00 | 3,885 | 7,770 | 29,206 | 33.1 K to 29.2 K (-11.74 %) |
Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.00 | 200 | 400 | 33,091 | 33.3 K to 33.1 K (-0.60 %) |
Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.00 | 400 | 800 | 33,291 | 33.7 K to 33.3 K (-1.19 %) |
Apr 11 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.01 | 450 | 902 | 33,691 | 34.1 K to 33.7 K (-1.32 %) |
Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.15 | 867 | 1,862 | 34,141 | 35 K to 34.1 K (-2.48 %) |
Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.15 | 1,800 | 3,872 | 35,008 | 36.8 K to 35 K (-4.89 %) |
Apr 06 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Sell | S | 2.25 | 1,000 | 2,250 | 36,808 | 37.8 K to 36.8 K (-2.64 %) |
Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 21,064 | 0 | 21,063 | |
Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | M | 0.00 | 21,064 | 0 | 37,808 | 16.7 K to 37.8 K (+125.80 %) |
Feb 08 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.99 | 75,000 | 224,250 | 75,000 | |
Jan 03 2017 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.38 | 26,400 | 89,232 | 26,400 | |
Aug 30 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 5.00 | 26,400 | 132,000 | 26,400 | |
Aug 19 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | P | 6.29 | 3,119 | 19,619 | 3,119 | |
Aug 19 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | P | 5.55 | 3,119 | 17,310 | 3,119 | |
Aug 19 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | P | 0.00 | 3,119 | 0 | 16,744 | 13.6 K to 16.7 K (+22.89 %) |
Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.00 | 155,867 | 0 | 311,733 | |
Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Payment of Exercise | F | 0.00 | 58,044 | 0 | 100,823 | 158.9 K to 100.8 K (-36.54 %) |
Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Buy | M | 0.00 | 155,867 | 0 | 158,867 | 3 K to 158.9 K (+5,195.57 %) |
Feb 18 2016 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.49 | 20,000 | 9,800 | 20,000 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | Chief Financial Off ... | Option Exercise | A | 0.00 | 467,600 | 0 | 467,600 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | Chief Financial Off ... | Option Exercise | A | 2.30 | 467,600 | 1,075,480 | 467,600 | |
Dec 14 2006 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | VP, CAO & Secretary | Grant | A | 0.00 | 17,400 | 0 | 22,563 | 5.2 K to 22.6 K (+337.01 %) |
May 26 2006 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, CAO | Buy | P | 9.68 | 100 | 968 | 5,163 | 5.1 K to 5.2 K (+1.98 %) |
May 26 2006 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, CAO | Buy | P | 9.67 | 100 | 967 | 5,063 | 5 K to 5.1 K (+2.01 %) |
May 26 2006 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, CAO | Buy | P | 9.69 | 300 | 2,907 | 4,963 | 4.7 K to 5 K (+6.43 %) |
May 26 2006 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, CAO | Buy | P | 9.65 | 600 | 5,790 | 4,663 | 4.1 K to 4.7 K (+14.77 %) |
Dec 08 2005 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, Fin ... | Option Exercise | A | 2.92 | 45,000 | 131,400 | 45,000 | |
Dec 08 2005 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, Fin ... | Option Exercise | A | 2.92 | 30,000 | 87,600 | 30,000 | |
Nov 12 2004 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, Fin ... | Option Exercise | A | 3.46 | 50,000 | 173,000 | 50,000 | |
Nov 12 2004 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, Fin ... | Option Exercise | A | 3.46 | 50,000 | 173,000 | 50,000 | |
Apr 08 2004 | AVNR | AVANIR PHARMACEUTI ... | HANSON GREGORY P | Vice President, Fin ... | Option Exercise | A | 1.78 | 10,000 | 17,800 | 10,000 |
Page: 1